Stapgen specializes in innovative medical devices for early diabetes detection. The STAP test measures intestinal alkaline phosphatase deficiency, identifying individuals at risk of Type 2 diabetes up to five years before onset. Committed to prevention, Stapgen aims to eradicate the Type 2 diabetes pandemic globally.
California, • United States
Minnesota, • United States
Illinois, • United States
Basel-City, • Switzerland
Basel-City, • Switzerland • Healthcare Technology
Diabetes management solutions, Innovative blood glucose monitoring, Advanced healthcare technology, Patient empowerment tools, Sustainability-focused operations
California, • United States
Hessen, • Germany